ArticleFrontiers in pediatrics2026
Hemodynamic profile of neonatal fungal sepsis with insights into the disease spectrum: a retrospective study.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neonatal fungal sepsis is a significant contributor to late-onset sepsis in neonatal intensive care units, particularly among preterm and low-birth-weight infants. While its epidemiology and microbiology are well described, the hemodynamic profile remains poorly characterized. This study aimed to evaluate the clinical spectrum with a focused assessment of cardiovascular alterations using functional echocardiography. Methods: Data for this retrospective observational study were collected from a tertiary care neonatal intensive care unit over a three-year period. Neonates with culture-proven fungal sepsis were included. Demographic, clinical, microbiological and outcome data were analyzed. Functional echocardiography was performed during active infection and repeated after microbiological clearance according to unit protocol. Paired hemodynamic comparisons were performed among survivors. Results: Twenty-six neonates with fungal sepsis were included, of whom 73.1% were preterm and predominantly low birth weight. Non- Conclusion: In this cohort, neonatal fungal sepsis was associated with reversible hemodynamic alterations, predominantly involving right ventricular function and the pulmonary circulation. Functional echocardiography may provide valuable physiological insights and assist targeted hemodynamic management. Although our study did not include a bacterial sepsis comparator cohort, the observed cardiovascular alterations are broadly consistent with those reported in published neonatal bacterial sepsis studies. Clinical trial registration: This study was registered with the Clinical Trials Registry of India (CTRI/2025/03/083270) on 23rd march 2025. Trial details are publicly accessible at https://ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=127824.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.